Influenza vaccine Oculorespiratory syndrome incidence is reduced in HIV
C Cooper, A Thorne… - Vaccine, 2011 - Elsevier
C Cooper, A Thorne…
Vaccine, 2011•ElsevierClinical experience suggests Oculorespiratory Syndrome (ORS) following influenza
vaccination is rare in HIV but this is not well evaluated. We assessed ORS incidence in a
randomized influenza vaccine trial of HIV participants. The overall incidence was 0.8%
suggesting that influenza vaccine ORS incidence is reduced in HIV.
vaccination is rare in HIV but this is not well evaluated. We assessed ORS incidence in a
randomized influenza vaccine trial of HIV participants. The overall incidence was 0.8%
suggesting that influenza vaccine ORS incidence is reduced in HIV.
Clinical experience suggests Oculorespiratory Syndrome (ORS) following influenza vaccination is rare in HIV but this is not well evaluated. We assessed ORS incidence in a randomized influenza vaccine trial of HIV participants. The overall incidence was 0.8% suggesting that influenza vaccine ORS incidence is reduced in HIV.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果